1
|
Heidenreich PA, Albert NM, Allen LA,
Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam
MA, Maddox TM, et al: Forecasting the impact of heart failure in
the United States: A policy statement from the American Heart
Association. Circ Heart Fail. 6:606–619. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Marti CN, Georgiopoulou VV and
Kalogeropoulos AP: Acute heart failure: Patient characteristics and
pathophysiology. Curr Heart Fail Rep. 10:427–433. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Mozaffarian D, Benjamin EJ, Go AS, Arnett
DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ,
Howard VJ, et al: Heart disease and stroke statistics-2015 update:
A report from the American Heart Association. Circulation.
131:e29–e322. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Fabbri A, Marchesini G, Carbone G,
Cosentini R, Ferrari A, Chiesa M, Bertini A and Rea F: Acute heart
failure in the emergency department: A follow-up study. Intern
Emerg Med. 11:115–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
5
|
Collins S, Storrow AB, Albert NM, Butler
J, Ezekowitz J, Felker GM, Fermann GJ, Fonarow GC, Givertz MM,
Hiestand B, et al: Early management of patients with acute heart
failure: state of the art and future directions. A consensus
document from the society for academic emergency medicine/heart
failure society of America acute heart failure working group. J
Card Fail. 21:27–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Madika AL, Fertin M, Hebbar E and Lamblin
N: 0202: Predictive factors of left ventricular recovery in acute
heart failure revealing reduced left ventricular ejection fraction.
Arch Cardiovas Dis Suppl. 8:262016.
|
7
|
Januzzi JL Jr, Camargo CA, Anwaruddin S,
Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT,
Chae CU, et al: The N-terminal Pro-BNP investigation of dyspnea in
the emergency department (PRIDE) study. Am J Cardiol. 95:948–954.
2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Roberts E, Ludman AJ, Dworzynski K,
Al-Mohammad A, Cowie MR, McMurray JJ and Mant J: NICE Guideline
Development Group for Acute Heart Failure: The diagnostic accuracy
of the natriuretic peptides in heart failure: Systematic review and
diagnostic meta-analysis in the acute care setting. BMJ.
350:h9102015. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Steinhart B, Thorpe KE, Bayoumi AM, Moe G,
Januzzi JL Jr and Mazer CD: Improving the diagnosis of acute heart
failure using a validated prediction model. J Am Coll Cardiol.
54:1515–1521. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Matsue Y, Suzuki M, Torii S, Yamaguchi S,
Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, et al:
Prognostic impact of early treatment with tolvaptan in patients
with acute heart failure and renal dysfunction. Int J Cardiol.
221:188–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Mcculloμgh PA: Scope of cardiovascular
complications in patients with kidney disease. Ethn Dis.
12:S3-44-82002.PubMed/NCBI
|
12
|
Homsak E and Ekart R: Hemodiafiltration
affects NT-proBNP but not ST2 serum concentration in end-stage
renal disease patients. Clin Biochem. 49:1159–1163. 2016.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Wang K, Li HL, Chen LL, Bei WJ, Lin KY,
Smyth B, Chen SQ, Guo XS, Guo W, Liu YH, et al: Association of
N-terminal pro-brain natriuretic peptide with contrast-induced
acute kidney injury and long-term mortality in patients with heart
failure and mid-range ejection fraction: An observation study.
Medicine (Baltimore). 96:e62592017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chenevier-Gobeaux C, Claessens YE, Voyer
S, Ekindjian OG, Ginsburg C and Desmoulins D: Concentrations
plasmatiques du peptide natriurétique type B (BNP) et du fragment
N-terminal du propeptide (NT-proBNP) aux urgences: Influence de la
fonction rénale. Immuno-Anal Biol Spé. 20:295–300. 2005.
|
15
|
Rothenburger M, Stypmann J, Wichter T, et
al: The role of NT-proBNP in chronic heart failure and renal
insufficiency. Thorac Cardiovasc Surg. 53:618–624. 2005. View Article : Google Scholar
|
16
|
Herrero-Puente P, Prieto-García B,
García-García M, Jacob J, Martín-Sánchez FJ, Pascual-Figal D, Bueno
H, Gil V, Llorens P, Vázquez-Alvarez J, et al: Predictive capacity
of a multimarker strategy to determine short-term mortality in
patients attending a hospital emergency Department for acute heart
failure. BIO-EAHFE study. Clin Chim Acta. 466:22–30. 2017.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Demissei BG, Cotter G, Prescott MF, Felker
GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Severin TM,
Wang Y, et al: A multimarker multi-time point-based risk
stratification strategy in acute heart failure: Results from the
RELAX-AHF trial. Eur J Heart Fail. 19:1001–1010. 2017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Scherer PE, Williams S, Fogliano M,
Baldini G and Lodish HF: A novel serum protein similar to C1q,
produced exclusively in adipocytes. J Biol Chem. 270:26746–26749.
1995. View Article : Google Scholar : PubMed/NCBI
|
19
|
Pischon T, Girman CJ, Hotamisligil GS,
Rifai N, Hu FB and Rimm EB: Plasma adiponectin levels and risk of
myocardial infarction in men. JAMA. 291:1730–1737. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zapata RC, Meachem MD, Cardoso NC, Mehain
SO, McMillan CJ, Snead ER and Chelikani PK: Differential
circulating concentrations of adipokines, glucagon and adropin in a
clinical population of lean, overweight and diabetic cats. BMC Vet
Res. 13:852017. View Article : Google Scholar : PubMed/NCBI
|
21
|
Bednarska-Makaruk M, Graban A, Wiśniewska
A, Łojkowska W, Bochyńska A, Gugała-Iwaniuk M, Sławińska K,
Ługowska A, Ryglewicz D and Wehr H: Association of adiponectin,
leptin and resistin with inflammatory markers and obesity in
dementia. Biogerontology. 18:561–580. 2017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Mazur-Bialy AI, Bilski J, Wojcik D,
Brzozowski B, Surmiak M, Hubalewska-Mazgaj M, Chmura A, Magierowski
M, Magierowska K, Mach T and Brzozowski T: Beneficial effect of
voluntary exercise on experimental colitis in mice fed a high-fat
diet: The role of irisin, adiponectin and proinflammatory
biomarkers. Nutrients. 9:pii: E410. 2017. View Article : Google Scholar : PubMed/NCBI
|
23
|
Bergmark BA, Cannon CP, White WB, Jarolim
P, Liu Y, Bonaca MP, Zannad F and Morrow DA: Baseline Baseline
adiponectin concentration and clinical outcomes among patients with
diabetes and recent acute coronary syndrome in the EXAMINE trial.
Diabetes Obes Metab. 19:962–969. 2017. View Article : Google Scholar : PubMed/NCBI
|
24
|
Ng RC and Chan KH: Potential
neuroprotective effects of adiponectin in Alzheimer's disease. Int
J Mol Sci. 18:pii: E592. 2017. View Article : Google Scholar
|
25
|
Norvik JV, Schirmer H, Ytrehus K, Jenssen
TG, Zykova SN, Eggen AE, Eriksen BO and Solbu MD: Low adiponectin
is associated with diastolic dysfunction in women: a
cross-sectional study from the Tromsø Study. BMC Cardiovasc Disord.
17:792017. View Article : Google Scholar : PubMed/NCBI
|
26
|
Tsukamoto O, Fujita M, Kato M, Yamazaki S,
Asano Y, Ogai A, Okazaki H, Asai M, Nagamachi Y, Maeda N, et al:
Natriuretic peptides enhance the production of adiponectin in human
adipocytes and in patients with chronic heart failure. J Am Coll
Cardiol. 53:2070–2077. 2009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Yanavitski M and Givertz MM: Novel
biomarkers in acute heart failure. Curr Heart Fail Rep. 8:206–211.
2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Yin WH, Wei J, Huang WP, Chen JW, Young MS
and Lin SJ: Prognostic value of circulating adipokine levels and
expressions of adipokines in the myocardium of patients with
chronic heart failure. Circ J. 76:2139–2147. 2012. View Article : Google Scholar : PubMed/NCBI
|
29
|
Yu HP, Jen HL, Yin WH and Wei J:
Circulating adiponectin levels following treatment can predict late
clinical outcomes in chronic heart failure. Acta Cardiol Sin.
33:139–149. 2017.PubMed/NCBI
|
30
|
Park M and Sweeney G: Direct effects of
adipokines on the heart: Focus on adiponectin. Heart Fail Rev.
18:631–644. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
McMurray JJ, Adamopoulos S, Anker SD,
Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C,
Gomez-Sanchez MA, et al: ESC guidelines for the diagnosis and
treatment of acute and chronic heart failure 2012: The task force
for the diagnosis and treatment of acute and chronic heart failure
2012 of the European Society of Cardiology. Developed in
collaboration with the heart failure association (HFA) of the ESC.
Eur J Heart Fail. 14:803–869. 2012. View Article : Google Scholar : PubMed/NCBI
|
32
|
Lamb EJ, Webb MC and O'Riordan SE: Using
the modification of diet in renal disease (MDRD) and Cockcroft and
Gault equations to estimate glomerular filtration rate (GFR) in
older people. Age Ageing. 36:689–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
33
|
Teixeira A, Arrigo M, Tolppanen H, Gayat
E, Laribi S, Metra M, Seronde MF, Cohen-Solal A and Mebazaa A:
Management of acute heart failure in elderly patients. Arch
Cardiovasc Dis. 109:422–430. 2016. View Article : Google Scholar : PubMed/NCBI
|
34
|
Fonseca C, Araújo I, Marques F, Brás D and
Bettencourt P: A closer look at acute heart failure: Putting
Portμguese and European data into perspective. Rev Port Cardiol.
35:291–304. 2016.(In English, Portuguese). View Article : Google Scholar : PubMed/NCBI
|
35
|
Collins SP, Storrow AB, Levy PD, Albert N,
Butler J, Ezekowitz JA, Felker GM, Fermann GJ, Fonarow GC, Givertz
MM, et al: Early management of patients with acute heart failure:
State of the art and future directions-a consensus document from
the SAEM/HFSA acute heart failure working group. Acad Emerg Med.
22:94–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
36
|
Harbaum L, Hennigs JK, Baumann HJ,
Lüneburg N, Griesch E, Bokemeyer C, Grünig E and Klose H:
N-terminal pro-brain natriuretic peptide is a useful prognostic
marker in patients with pre-capillary pulmonary hypertension and
renal insufficiency. PLoS One. 9:e942632014. View Article : Google Scholar : PubMed/NCBI
|
37
|
Nishikimi T, Futoo Y, Tamano K, Takahashi
M, Suzuki T, Minami J, Honda T, Uetake S, Asakawa H, Kobayashi N,
et al: Plasma brain natriuretic peptide levels in chronic
hemodialysis patients: influence of coronary artery disease. Am J
Kidney Dis. 37:1201–1208. 2001. View Article : Google Scholar : PubMed/NCBI
|
38
|
McCulloμgh PA: Cardiorenal risk: An
important clinical intersection. Rev Cardiovasc Med. 3:71–76.
2002.PubMed/NCBI
|
39
|
Bersch-Ferreira ÂC, Sampaio GR, Gehringer
MO, Ross-Fernandes MB, Kovacs C, Alves R, Pereira JL, Magnoni CD,
Weber B and Rogero MM: Association between polyunsaturated fatty
acids and inflammatory markers in patients in secondary prevention
of cardiovascular disease. Nutrition. 37:30–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
40
|
Smekal A and Vaclavik J: Adipokines and
cardiovascular disease: A comprehensive review. Biomed Pap Med Fac
Univ Palacky Olomouc Czech Repub. 161:31–40. 2017. View Article : Google Scholar : PubMed/NCBI
|
41
|
Baldasseroni S, Mannucci E, Orso F, Di
Serio C, Pratesi A, Bartoli N, Marella GA, Colombi C, Foschini A,
Valoti P, et al: Adiponectin in outpatients with coronary artery
disease: Independent predictors and relationship with heart
failure. Nutr Metab Cardiovasc Dis. 22:292–299. 2012. View Article : Google Scholar : PubMed/NCBI
|
42
|
Zhang H, Mo X, Hao Y, Huang J, Lu X, Cao J
and Gu D: Adiponectin levels and risk of coronary heart disease: A
meta-analysis of prospective studies. Am J Med Sci. 345:455–461.
2013. View Article : Google Scholar : PubMed/NCBI
|
43
|
Akbarpour M: The effect of aerobic
training on serum adiponectin and leptin levels and inflammatory
markers of coronary heart disease in obese men. Biol Sport.
30:21–27. 2013. View Article : Google Scholar : PubMed/NCBI
|
44
|
Ritsinger V, Brismar K, Malmberg K,
Mellbin L, Näsman P, Rydén L, Söderberg S, Tenerz Å and Norhammar
A: Elevated levels of adipokines predict outcome after acute
myocardial infarction: A long-term follow-up of the glucose
tolerance in patients with acute myocardial Infarction cohort. Diab
Vasc Dis Res. 14:77–87. 2017. View Article : Google Scholar : PubMed/NCBI
|
45
|
Arsenault BJ, Kohli P, Lambert G, DeMicco
DA, Laskey R, Messig MM, Kastelein JJ and Waters DD: Emerging
cardiovascular disease biomarkers and incident diabetes mellitus
risk in statin-treated patients with coronary artery disease (from
the treating to new targets [TNT] study). Am J Cardiol.
118:494–498. 2016. View Article : Google Scholar : PubMed/NCBI
|
46
|
Dries DL, Exner DV, Domanski MJ, Greenberg
B and Stevenson LW: The prognostic implications of renal
insufficiency in asymptomatic and symptomatic patients with left
ventricular systolic dysfunction. J Am Coll Cardiol. 35:681–689.
2000. View Article : Google Scholar : PubMed/NCBI
|
47
|
Lim CC, Teo BW, Tai ES, Lim SC, Chan CM,
Sethi S, Wong TY and Sabanayagam C: Elevated serum leptin,
adiponectin and leptin to adiponectin ratio is associated with
chronic kidney disease in Asian adults. PLoS One. 10:e01220092015.
View Article : Google Scholar : PubMed/NCBI
|
48
|
Markaki A, Psylinakis E and Spyridaki A:
Adiponectin and end-stage renal disease. Hormones (Athens).
15:345–354. 2016. View Article : Google Scholar : PubMed/NCBI
|
49
|
Taherimahmoudi M, Ahmadi H, Mehrsai A and
Pourmand G: Plasma adiponectin concentration and insulin
resistance: role of successful kidney transplantation. Transplant
Proc. 42:797–800. 2010. View Article : Google Scholar : PubMed/NCBI
|
50
|
Bakkaloglu SA, Buyan N, Funahashi T,
Pasaoglu H, Elhan AH, Hasanoglu E and Soylemezoglu O: Adiponectin
levels and atherosclerotic risk factors in pediatric chronic
peritoneal dialysis patients. Perit Dial Int. 25:357–361.
2005.PubMed/NCBI
|
51
|
Kamimura MA, Canziani ME, Sanches FR,
Velludo CM, Carrero JJ, Bazanelli AP, Draibe SA and Cuppari L:
Variations in adiponectin levels in patients with chronic kidney
disease: A prospective study of 12 months. J Bras Nefrol.
34:259–265. 2012. View Article : Google Scholar : PubMed/NCBI
|